BioCrossroads

Entrepreneur says quality of venture capital as important as quantity

January 2, 2010
 IBJ Staff
Jim Pearson knows a thing or two about raising money from venture capitalists. And he has some advice for BioCrossroads: Teach entrepreneurs the value of money.
More

First Indiana Future Fund off to a slow startRestricted Content

December 19, 2009
Peter Schnitzler
More than half of the venture capital fund's original investors took a pass on its $58 million successor, the newly launched INext.
More

New BioCrossroads venture fund raises $58 million

December 16, 2009
Peter Schnitzler
The new INext fund is the successor to the $73 million Indiana Future Fund, which the life science initiative raised in 2003.
More

Company's medical device earns expedited review

December 9, 2009
FAST Diagnostics LLC said initial human trials on its method to measure kidney function faster and more accurately than existing techniques could begin as early as next year, with commercialization following by 2012.
More

Downtown life sciences corridor flagged for development

November 28, 2009
 IBJ Staff
A new task force is charged with making recommendations for development of the city’s downtown certified technology park.
More

Aarden Pharmaceuticals chose Indianapolis over San Diego for headquarters

November 14, 2009
 IBJ Staff
Thanks partly to a state grant and support from Indiana’s BioCrossroads life sciences initiative, principals “decided locating here would give Aarden a better chance of success.
More

TechPoint to focus on IT firms specializing in medical, life sciences sectorsRestricted Content

October 31, 2009
Chris O'Malley
Long tracking the emergence of information technology firms involved in the health and life sciences sector, the state’s IT trade group, TechPoint, is undergoing a mitosis of sorts to help fuel the trend. It has created Advancing Life Science & Health Care Information Technology, or ALHIT, which will focus on growing this subset of the IT realm.
More

Indianapolis-based FAST Diagnostics gets funding from BioCrossroads' seed fund

October 24, 2009
 IBJ Staff
Money will help the company refine its tool to treat acute kidney injury.
More

State's health IT groups seek stimulus funds

October 16, 2009
Some of Indiana's leading organizations in health information technology are collaborating on an effort to receive several million dollars of stimulus funding.
More

Indiana life sciences leaders discover dozens of tiny outsourcing companiesRestricted Content

October 10, 2009
Chris O'Malley
BioCrossroads, an Indianapolis-based not-for-profit, is cataloging Indiana businesses offering contract services to pharmaceutical and biotechnology companies, and discovering many small firms operating in relative obscurity.
More

Lilly Endowment funds OrthoWorx effort with $7 million

September 23, 2009
J.K. Wall
A new group expected to develop the orthopedic implants industry in Warsaw will be able to proceed now that Indianapolis-based Lilly Endowment Inc. is putting $7 million behind it, according to an announcement this morning.
More

BioCrossroads rolls out orthopedic initiative

September 10, 2009
J.K. Wall
With job growth surging in Warsaw's orthopedic cluster, the life sciences development group BioCrossroads Inc. set out to...
More

Emerging life sciences companies grabbing more in government grantsRestricted Content

August 10, 2009
Chris O'Malley
More emerging life science companies have found life in the form of federal Small Business Innovation Research grants.
More

Indiana playing trailblazing role in drive to tailor pharmaceuticals to genetic makeup of individualsRestricted Content

April 13, 2009
Chris O'Malley
Indiana is becoming not only a hotbed of "pharmacogenomics" research, but also a trailblazer in finding practical ways to use it on the practitioner level.
More

Advanced energy next focus for economic developmentRestricted Content

February 16, 2009
Chris O'Malley
The Central Indiana Corporate Partnership—the parent of the BioCrossroads, TechPoint and Conexus industry cluster initiatives—let it be known last month that there would be a fourth leg to its economic development stool: clean technology.
More

Grants will shrink, life sciences leader predictsRestricted Content

January 19, 2009
Scott Olson
Last fall, BioCrossroads named Leonard J. Betley—chairman of the Richard M. Fairbanks Foundation, the Regenstrief Foundation and the Walther Cancer Foundation—its inaugural Life Sciences Champion of the Year. IBJ recently caught up with Betley to get his thoughts on the latest life sciences developments and gauge the climate for fund raising.
More

State's tech sector looking ahead, but cutting backRestricted Content

January 12, 2009
It's two steps forward, one step back, for Indiana's technology sector, but in a tough economic climate, any advancement is worth celebrating.
More

Biotech venture fund in worksRestricted Content

January 5, 2009
Peter Schnitzler
BioCrossroads is setting the stage to create Indiana Future Fund II, an effort that would raise tens of millions of dollars for speculation on promising Hoosier life science companies.
More

Report sees jackpot with BioCrossroads, but expert sees obstaclesRestricted Content

February 4, 2008
J.K. Wall
Three months after launching an initiative to boost drug-development firms in Indiana, officials at BioCrossroads have written a report that attempts to show in detail the vast market opportunity they see.
More

Life sciences initiative seeks to increase California tiesRestricted Content

June 11, 2007
Peter Schnitzler
BioCrossroads is exploring an unusual new strategy to boost the development of Indiana's life sciences industry: Team up with San Diego. Advocates say it's a novel approach with enormous potential for Indiana.
More

Ex-Lilly execs take on diabetes with Carmel startupRestricted Content

November 6, 2006
Peter Schnitzler
Four former top scientists at Eli Lilly and Co. have formed a Carmel-based company to develop diabetes therapies--a venture observers say has the potential to become the kind of blockbuster success BioCrossroads was built to stimulate.
More
Page  << 1 2 3 pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. How can any company that has the cash and other assets be allowed to simply foreclose and not pay the debt? Simon, pay the debt and sell the property yourself. Don't just stiff the bank with the loan and require them to find a buyer.

  2. If you only knew....

  3. The proposal is structured in such a way that a private company (who has competitors in the marketplace) has struck a deal to get "financing" through utility ratepayers via IPL. Competitors to BlueIndy are at disadvantage now. The story isn't "how green can we be" but how creative "financing" through captive ratepayers benefits a company whose proposal should sink or float in the competitive marketplace without customer funding. If it was a great idea there would be financing available. IBJ needs to be doing a story on the utility ratemaking piece of this (which is pretty complicated) but instead it suggests that folks are whining about paying for being green.

  4. The facts contained in your post make your position so much more credible than those based on sheer emotion. Thanks for enlightening us.

  5. Please consider a couple of economic realities: First, retail is more consolidated now than it was when malls like this were built. There used to be many department stores. Now, in essence, there is one--Macy's. Right off, you've eliminated the need for multiple anchor stores in malls. And in-line retailers have consolidated or folded or have stopped building new stores because so much of their business is now online. The Limited, for example, Next, malls are closing all over the country, even some of the former gems are now derelict.Times change. And finally, as the income level of any particular area declines, so do the retail offerings. Sad, but true.

ADVERTISEMENT